Search research articles
Contact Us
Filters
Showing results (151-160 of 154) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 154 results.
Cancer Research
|
January 8, 2000
Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18
J A Morgan, Y Yin, A D Borowsky, et al.
Genes & Development
|
September 7, 2001
Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily
G Steele-Perkins, W Fang, X H Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2016
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy
E Ben-Ami, C M Barysauskas, M von Mehren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
G D Demetri, C R Antonescu, B Bjerkehagen, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 154) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 154 results.
Cancer Research
|
January 8, 2000
Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18
J A Morgan, Y Yin, A D Borowsky, et al.
Genes & Development
|
September 7, 2001
Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily
G Steele-Perkins, W Fang, X H Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2016
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy
E Ben-Ami, C M Barysauskas, M von Mehren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
G D Demetri, C R Antonescu, B Bjerkehagen, et al.
Page
of 16